688166 博瑞医药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.3682.2237.9628.88012.384
总资产报酬率 ROA (%)0.1500.9933.7154.1786.280
投入资产回报率 ROIC (%)0.1681.1034.0204.5036.910

边际利润分析
销售毛利率 (%)56.77150.83457.51055.79463.011
营业利润率 (%)-1.1351.19812.49816.12923.803
息税前利润/营业总收入 (%)5.4055.40515.44718.05124.771
净利润/营业总收入 (%)2.9243.02011.01414.70320.783

收益指标分析
经营活动净收益/利润总额(%)126.729138.754114.473105.52296.612
价值变动净收益/利润总额(%)-51.582-39.807-11.026-8.0840.232
营业外收支净额/利润总额(%)-6.090-5.430-1.965-0.7810.021

偿债能力分析
流动比率 (X)2.3271.3971.5591.9952.388
速动比率 (X)1.9651.1121.2121.6212.043
资产负债率 (%)55.60051.13752.92051.95451.908
带息债务/全部投入资本 (%)51.83445.13247.21947.83648.341
股东权益/带息债务 (%)82.858108.267106.877105.609105.323
股东权益/负债合计 (%)69.63984.64187.39790.60490.579
利息保障倍数 (X)0.8351.2664.8438.82025.716

营运能力分析
应收账款周转天数 (天)97.15294.76585.71789.395119.636
存货周转天数 (天)231.548218.075234.266215.752229.802